FERRUCCI, VERONICA
 Distribuzione geografica
Continente #
EU - Europa 571
NA - Nord America 525
AS - Asia 276
AF - Africa 29
SA - Sud America 2
Totale 1.403
Nazione #
US - Stati Uniti d'America 519
IT - Italia 366
SG - Singapore 127
NL - Olanda 58
CN - Cina 55
VN - Vietnam 55
GB - Regno Unito 38
UA - Ucraina 37
DE - Germania 34
IN - India 33
CI - Costa d'Avorio 28
FI - Finlandia 11
IE - Irlanda 6
CA - Canada 5
ES - Italia 5
FR - Francia 5
PL - Polonia 3
BR - Brasile 2
CH - Svizzera 2
ID - Indonesia 2
SE - Svezia 2
TR - Turchia 2
CZ - Repubblica Ceca 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PK - Pakistan 1
SI - Slovenia 1
Totale 1.403
Città #
Singapore 111
Chandler 76
Naples 75
Napoli 65
Ashburn 60
Amsterdam 56
Dong Ket 55
Santa Clara 22
Millbury 21
Boston 18
Salerno 18
Lawrence 15
Des Moines 13
Rome 12
Milan 11
Nanjing 10
Princeton 10
Rende 8
Washington 8
Wilmington 8
Battipaglia 7
Beijing 7
Munich 7
Jiangmen 6
Casavatore 5
Caserta 5
Helsinki 5
Lissone 5
Los Angeles 5
Poli 5
Pomigliano D'arco 4
Portici 4
Shanghai 4
Kronberg 3
Palermo 3
Seattle 3
Sudbury 3
Altamura 2
Campinas 2
Dublin 2
Fairfield 2
Fort Worth 2
Giugliano in Campania 2
Indore 2
Izmir 2
Jiaxing 2
Lappeenranta 2
Malang 2
Marano di Napoli 2
Marcianise 2
Nanchang 2
Norwalk 2
Nova Siri 2
Padova 2
Paternopoli 2
Pozzuoli 2
Pune 2
Quartu Sant'elena 2
Redwood City 2
San Giorgio a Cremano 2
Sant'Anastasia 2
Toronto 2
Trento 2
Acerra 1
Bari 1
Bascape 1
Bern 1
Boardman 1
Bologna 1
Castellamonte 1
Cerignola 1
Changsha 1
Dallas 1
Dongyang 1
Ercolano 1
Fara Novarese 1
Formia 1
Fort St. James 1
Genoa 1
Giaveno 1
Gragnano 1
Groningen 1
Lambeth 1
Lausanne 1
Livorno 1
Ljubljana 1
Marigliano 1
Mondragone 1
Mugnano Di Napoli 1
Mugnano di Napoli 1
Nottingham 1
Ottawa 1
Panama City 1
Peshawar 1
Pittsburgh 1
Prague 1
Redmond 1
Riga 1
San Leucio 1
San Mango 1
Totale 842
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 144
PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment 93
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition. 70
A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: therapeutic applications in cancer. 61
Early targets of miR-34a in neuroblastoma 57
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines 56
Natural compounds for pediatric cancer treatment 51
Glioblastoma stem cells differentiation through epigenetic modulation is driven by miR-296-5p/HMGA1/Sox2 axis 51
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 51
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 47
In vivo bioluminescence imaging using orthotopic xenografts towards patient's derived-xenograft Medulloblastoma models 46
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 46
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 44
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 42
Heterogeneity within the PF-EPN-B ependymoma subgroup 40
A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine 39
The phenotypic and molecular spectrum of PEHO syndrome and PEHO-like disorders 38
Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer. 37
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 36
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients—A Target for SARS-CoV-2 Propagation 36
Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes 35
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 34
Pattern of Relapse and Treatment Response in WNT- Activated Medulloblastoma 34
Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry 34
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 34
DDDR-32. A NEW IMMUNOMODULATORY FUNCTION OF PYRIDO-PYRIMIDINE DERIVATIVES TO IMPAIR METASTATIC GROUP 3 MEDULLOBLASTOMA IN VIVO 30
SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets 23
Functional Genomics of PRUNE1 in Neurodevelopmental Disorders (NDDs) Tied to Medulloblastoma (MB) and Other Tumors 19
Epigenetics and immune cells in medulloblastoma 16
Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules 15
Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties 14
The physiological polyphosphate as a healing biomaterial for chronic wounds: Crucial roles of its antibacterial and unique metabolic energy supplying properties 14
Failure of human rhombic lip differentiation underlies medulloblastoma formation 13
International Patent n. WO2021215617, PCT/KR2020/018989, pdpb204052; “Composition for preventing or disinfecting coronavirus infection or disease caused by coronavirus infection comprising polyphosphate” 12
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication 10
Italian patent: 102020000028628; “Metodo per prevedere la formazione di metastasi in pazienti tumorali” 10
Italian Patent: n. 102024000005170. “Nutraceutical composition containing Propolis, Verbascum, Thymus, Polyphosphates, Potassium Sorbate and Sodium Benzoate with antiviral (SARS-CoV-2, influenza A and B, RNA herpes viruses), anti-inflammatory, antibacterial, antifungal and prebiotic activities” 8
Patent: PCT/EP2021/087512 n. 10202000003235: “Method for determining active SARS-CoV-2 infections”; “Metodo per determinare infezioni attive da sars-cov-2” 8
EP24192124.6. Composition with antiviral, antibacterial and antifungal activity. 7
International patent: PCT/EP2023/079960 - WO/2024/089190 - EP4361137; “Prune_1 inhibitors and therapeutic use thereof” 6
Patent n. EP22154018: “Antisense compounds for the treatment of coronavirus infection” 6
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases 4
Italian Patent: n. 102023000016338; “Composition with antiviral, antibacterial and antifungal activity” 4
Italian Patent: n. 102023000022647; “ELYSIVIR against the PI3K/Akt and TGF beta signaling cascade during SARS-CoV-2 viral infection” 3
SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB 2
Totale 1.480
Categoria #
all - tutte 6.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 1 8 1 5 1 6 7 0
2020/2021118 6 0 0 0 2 4 20 8 5 7 10 56
2021/2022324 17 1 5 1 7 3 15 12 127 14 65 57
2022/2023275 26 6 6 7 33 28 4 21 59 53 24 8
2023/2024278 9 34 43 22 26 40 12 38 10 6 29 9
2024/2025266 54 33 48 58 73 0 0 0 0 0 0 0
Totale 1.480